CA Patent

CA2678907C — Modulators of pharmacokinetic properties of therapeutics

Assigned to Gilead Sciences Inc · Expires 2014-06-17 · 12y expired

What this patent protects

The present application provides for a compound of formula: (see above formula) or a pharmaceutically acceptable salt thereof, compositions or combinations containing such compounds and uses thereof for inhibiting cytochrome P450 monooxygenase or for modifying the pharmacokinetic…

USPTO Abstract

The present application provides for a compound of formula: (see above formula) or a pharmaceutically acceptable salt thereof, compositions or combinations containing such compounds and uses thereof for inhibiting cytochrome P450 monooxygenase or for modifying the pharmacokinetics of a drug which is metabolized by cytochrome P450 monooxygenase.

Drugs covered by this patent

Patent Metadata

Patent number
CA2678907C
Jurisdiction
CA
Classification
—
Expires
2014-06-17
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.